A new COVID variant is spreading in the US: What are the symptoms?
A new COVID-19 variant that was unheard of just months ago is now projected to be the second-most common strain in the U.S.
Variant NB.1.8.1 was first detected in China in January but accounted for about 0% of cases in the U.S. until May. By early June, it was estimated to account for up to 37%, according to the U.S. Centers for Disease Control (CDC).
The World Health Organization (WHO) evaluated the additional public health risk posed by the variant as "low at the global level in a May report, in which it also advised that currently approved COVID-19 vaccines are "expected to remain effective to this variant against symptomatic and severe disease."
Here's what we know about NB.1.8.1.
'Razor blade throat': What to know about COVID-19 variant NB.1.8.1
What is NB.1.8.1?
NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent right now, Subhash Verma, microbiology and immunology professor at the University of Nevada, Reno, previously told USA TODAY in May.
The new variant was first detected in January in China. As of mid-May, the variant had reached 10.7% of global reported COVID-19 cases, according to the World Health Organization (WHO).
Verma previously said NB.1.8.1 may be able to be transferred more easily than LP.8.1. Additionally, he said that NB.1.8.1 is able to evade antibodies created by vaccines or past infections more easily than LP.8.1.
"NB.1.8.1 is likely to spread more rapidly and evade our immune defenses more easily than LP.8.1, which is why this variant requires careful monitoring," Verma said.
How common is NB.1.8.1?
For a two-week period starting on May 25 and ending on June 7, the CDC's Nowcast estimates tracker shows projections for the different COVID-19 variants. According to the latest CDC data, the NB.1.8.1 strain is projected to be the second highest in the U.S., making up 37% of the total cases recorded in the U.S.
The most common strain is LP.8.1, also known as Omicron, which accounts for 38% of cases, followed by NB.1.8.1 with 37%, XFG with 8%, XFC making up 7%, and LF.7.9 with 4%.
The prominence of NB.1.8.1 in the U.S. has significantly increased in recent weeks, accounting for 0% of cases through March before reaching 2% in April, 5% in early May and 15% by late May.
What are the symptoms of NB.1.8.1?
The CDC has not outlined symptoms that are specific to the NB.1.8.1. variant. Verma said that NB.1.8.1 symptoms appear similar to those of earlier COVID-19 variants.
However, an extremely sore throat, colloquially called "razor blade throat," has been associated with the new variant.
People with the variant have reported a feeling akin to their throats being covered with razor blades, according to the Los Angeles Times, Fox News, SF Gate, and other news outlets. Many people have also taken to social media to describe the "razor blade throat."
The CDC outlines the following as common COVID-19 symptoms:
The CDC advises seeking medical care if you experience any of the following symptoms:
How can you protect yourself from NB.1.8.1 and other variants?
The World Health Organization states that currently approved COVID-19 vaccines are expected to remain effective against the NB.1.8.1 variant.
In a webpage dated Jan. 7, 2025, the CDC advises that everyone over the age of six months get the 2024-2025 COVID-19 vaccine, specifically the 2024-2025 Moderna COVID-19 Vaccine.
It also suggests that people who have never received a COVID-19 vaccine, are age 65 and older, are immunocompromised, live at a long-term care facility, are pregnant, breastfeeding, trying to get pregnant, and/or want to avoid getting long COVID, should get the vaccine, especially.
However, Health and Human Services Secretary Robert F. Kennedy Jr. said on May 27 that the COVID-19 vaccine would no longer be included in the CDC's recommended immunization schedule for healthy children and pregnant women, a move that broke with previous expert guidance and bypassed the normal scientific review process.
Under the changes, the only people who will be recommended for COVID-19 vaccines are those over 65 and people with existing health problems. This could make it harder for others who want the COVID-19 vaccine to get it, including health care workers and healthy people under 65 with a vulnerable family member or those who want to reduce their short-term risk of infection.
This could mean that some who still wish to receive the vaccine may have to pay out of pocket, if they are able to access it at all. It is not yet known how accessible the COVID-19 vaccine will be moving forward.
How to (still) get a COVID-19 test for free
Increasing Community Access to Testing, Treatment and Response (ICATT), a federal program, continues to provide free COVID-19 testing to individuals without health insurance.
According to the CDC, as of May 27, more than 19,000 locations across the country offer free testing. To find a location near you that offers free testing, visit testinglocator.cdc.gov/Search.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
42 minutes ago
- Time Business News
Child Growth Chart Calculator UK – Track Your Child's Development Percentile
It's natural to wonder if your child is growing as expected. Thankfully, growth charts make it easy to track development and spot any concerns early. The Child Growth Chart Calculator UK allows parents to compare their child's stats against NHS and WHO growth standards — providing peace of mind and professional-grade accuracy. Child Growth Chart Calculator UK systems have become increasingly sophisticated, thanks to evidence-based tools developed by leading pediatric organizations. The Royal College of Paediatrics and Child Health (RCPCH) provides comprehensive growth charts that healthcare professionals and parents can use to track development from birth through adolescence. A reliable Child Growth Chart Calculator UK uses WHO (World Health Organisation) growth standards, which describe optimal growth patterns for healthy, breastfed children. These calculators are available in two main categories: UK-WHO growth charts for 0-4 years and UK-WHO growth charts for 2-18 years, ensuring continuous monitoring throughout childhood and adolescence. Centile charts (also called percentile charts) are fundamental tools that pediatricians use to assess whether a child's growth falls within expected ranges. These charts don't simply tell you if measurements are 'normal' or 'abnormal' — instead, they show where your child's measurements fit within the statistical distribution of children their age and gender. Healthcare professionals plot your child's height, weight, and head circumference (for babies) on these charts during routine check-ups. The charts include several important features: BMI Centile Lookup: Modern UK growth charts include Body Mass Index calculations that account for a child's age and gender, providing more accurate assessments than simple height-to-weight ratios. Adult Height Predictor: Advanced charts can estimate a child's potential adult height based on current growth patterns and parental heights. Mid-Parental Height Comparator: This feature compares a child's growth against their genetic potential based on both parents' heights. Puberty Guidance: Charts for older children include guidance on the onset and progression of puberty, helping identify early or delayed development. Understanding centile results can initially seem complex, but the system is designed to be intuitive once you grasp the basics. Here's what you need to know: Healthy Weight Ranges: According to NHS guidelines, a healthy weight result falls between the 3rd and 91st centile. This means that 88% of children fall within this range, representing normal variation in healthy growth patterns. The 50th Centile Myth: Many parents assume their child should be at the 50th centile (the average), but this is a common misconception. A child at the 10th centile is just as healthy as one at the 75th centile, provided they're growing consistently along their curve. Growth Patterns Matter More Than Single Measurements: Healthcare professionals look for consistent growth patterns rather than focusing on individual measurements. A child who consistently tracks along the 25th centile is typically healthier than one whose measurements jump dramatically between centiles. Normal Variation Range: Approximately 99% of children with healthy growth and development fall between the 0.4th and 99.6th centile. Children outside this range require assessment, though many factors can contribute to measurements outside typical ranges. BMI Considerations: For children and teenagers, BMI is given as a centile because young people are still growing. The NHS BMI calculator takes into account age, sex, height, and weight to provide accurate assessments. While growth charts are excellent monitoring tools, certain situations warrant professional medical attention: Measurements Below the 0.4th Centile: Children whose height falls below the 0.4th centile (less than 2 standard deviations below the mean) may have short stature that requires evaluation. However, many cases represent normal physiological variations such as familial short stature or constitutional growth delay. Crossing Multiple Centile Lines: If your child's growth pattern suddenly changes and crosses two or more centile lines (either upward or downward), this may indicate an underlying issue requiring assessment. Extreme BMI Measurements: Children with BMI measurements consistently above the 91st centile or below the 3rd centile should be evaluated by healthcare professionals. Concerning Symptoms: Seek medical advice if growth concerns are accompanied by other symptoms such as poor appetite, excessive fatigue, delayed development, or other health issues. Parental Concerns: Trust your instincts as a parent. If you're worried about your child's growth despite normal chart results, discuss your concerns with your GP or health visitor. Modern Child Growth Chart Calculator UK tools make it easier than ever for parents to monitor their children's development between healthcare appointments. These calculators use the same WHO standards and NHS guidelines that healthcare professionals rely on, providing accurate assessments you can trust. When choosing a Child Growth Chart Calculator UK, ensure it: Uses current WHO/NHS standards Accounts for your child's exact age and gender Provides centile results rather than simple 'normal/abnormal' classifications Includes guidance on interpreting results The best Child Growth Chart Calculator UK systems integrate multiple measurement parameters including height, weight, BMI, and head circumference for comprehensive growth assessment. Avoid Over-Monitoring: While growth tracking is valuable, avoid weighing or measuring your child too frequently. Daily fluctuations are normal and can cause unnecessary anxiety for both parents and children. Individual Variations: Remember that every child grows at their own pace. Siblings may have completely different growth patterns while both being perfectly healthy. Nutritional Factors: Breastfeeding, family dietary habits, and overall nutrition can influence growth patterns. The WHO standards are based on optimal growth conditions for breastfed infants. Genetic Factors: Family history plays a significant role in growth patterns. Children often follow growth trajectories similar to their parents. Premature Birth Considerations: For babies born prematurely, healthcare professionals may use adjusted ages for the first few years to account for early birth. Healthcare professionals use growth charts as part of comprehensive assessments that include: Physical examinations Developmental milestone assessments Family history reviews Nutritional evaluations When necessary, additional testing or referrals to specialists The UK's systematic approach to growth monitoring, combining WHO standards with NHS protocols, ensures that children receive appropriate care while avoiding unnecessary interventions for normal growth variations. Regular monitoring through your child's routine health checks, combined with occasional use of a reliable Child Growth Chart Calculator UK, provides the best approach to ensuring healthy development. When in doubt, always consult with your GP, health visitor, or pediatrician who can provide personalized guidance based on your child's complete health picture. Remember, Child Growth Chart Calculator UK tools are designed for tracking patterns over time rather than defining what's 'normal' for every child. Every child is unique, and healthy growth comes in many different forms. TIME BUSINESS NEWS
Yahoo
3 hours ago
- Yahoo
The CDC won't fund local organizations' HIV prevention, ignoring KY health needs
In a recent decision, the Centers for Disease Control and Prevention (CDC) abruptly eliminated $200,000 in annual HIV prevention funding to AVOL Kentucky, a trusted, community-based nonprofit that has served Kentuckians for more than 30 years. This decision wasn't based on poor performance. Quite the opposite, AVOL Kentucky exceeded every benchmark and was preparing to expand outreach in the region. But in a sweeping national overhaul of HIV prevention funding, the CDC chose to bypass local and statewide community organizations like ours. For context, AVOL's persistence over the past three-plus decades melted the willful ignorance of the problem on the part of federal actors. AVOL Kentucky began to receive funding to provide direct HIV prevention outreach, and ever since we have been a critical part of the federal and state government's approach to stopping the spread of HIV. What began as a smattering of Lexingtonians trying to help their neighbors grew to an organization that serves all 120 Kentucky counties. Today we are at the most difficult last mile of prevention and health care delivery, without which the current successes in HIV management would not be possible. To be clear, this wasn't a budget cut. The funding is still there, just no longer supporting AVOL or similar service providers. As a result, Kentuckians will pay the price. More Kentuckians WILL get HIV, and our state will become less healthy. The CDC's decision to bypass trusted, grassroots organizations in favor of institutions that often lack presence in the communities most in need is a step backward. It creates a cascade of consequences: delayed testing, fewer prevention tools, disrupted care and the dismantling of years of trust built by local educators and advocates. At AVOL Kentucky, where I serve as board president, we assist all 120 counties across the commonwealth, many of which are rural and underserved parts of our state. Our staff and volunteers conduct more than 1,500 HIV tests annually and distribute thousands of condoms, educational materials and prevention resources. We connect individuals to affirming providers, help navigate testing and treatment and often serve as the first point of contact for those who are uninsured or unsure where else to turn. In many communities, we're not just a resource, we're the only resource. Opinion: As a family court judge, I know chronic absenteeism is a public health crisis These services matter. Kentucky has some of the highest rates of HIV and Hepatitis C in the country. Without consistent prevention efforts, and without trusted local providers offering these services without judgment, infection rates will rise, public health systems will become strained and individuals who are already vulnerable will become even more isolated. Often those who walk into our doors do not have health insurance, so our free services are the only way they can readily get sexual health testing and information. Our specialists work with those clients to explore their options to get covered. The CDC's decision ignores the unique realities of rural states like ours. Transportation, broadband access and stigma already create significant barriers to care. Replacing a responsive, community-rooted organization with a research institution, however well-intentioned, doesn't address those barriers. In many cases, it makes them worse. The secondary effect of regular, judgment-free access to sexual health care through AVOL Kentucky is increased, overall good health. Studies show that gaining access to HIV testing leads to increased testing for other sexually transmitted infections and more immediate treatment. It leads to increased condom use, and it reduces psychological strain from HIV-related anxiety. These improvements translate into fewer emergency room visits, lower long-term health care costs and longer, healthier lives. It's the kind of preventive care we should all be championing. Instead, AVOL Kentucky is being asked to do more with less, or in this case, to do the same life-saving work without the federal funding that has long sustained it. I've served on the board of AVOL Kentucky for many years, and I've watched firsthand how our team meets people where they are, literally and figuratively. Whether at pride festivals, churches, recovery centers or food pantries, AVOL shows up with compassion, integrity and information. There's no substitute for that kind of consistent, local presence. It can't be replicated by a new grant or an outside institution. Agree or disagree? Submit a letter to the editor. Roy Harrison is the board president of AVOL Kentucky. This article originally appeared on Louisville Courier Journal: Kentucky needs CDC funds for local HIV prevention | Opinion
USA Today
4 hours ago
- USA Today
As new variant spreads, what's the latest COVID-19 vaccine guidance? It's complicated.
As a new COVID-19 variant takes over in the U.S., guidance surrounding vaccines has become increasingly confusing. Changes in vaccination guidelines, ever-evolving variants and strains, along with threats to health insurance, have sent average Americans looking for the latest recommendations as members of the federal government often conflict with independent medical agencies and healthcare professionals. In the two weeks leading up to June 21, the Centers for Disease Control and Prevention (CDC) reported just shy of 14,500 positive COVID tests, and while hospitalizations and deaths are fortunately down significantly since the pandemic's peak, vulnerable people are still grappling with limiting their risk amid changing practices. Having trouble keeping track of variants and vaccines? Here's what we know. What is the new NB.1.8.1 COVID variant? NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent right now, Subhash Verma, microbiology and immunology professor at the University of Nevada, Reno, previously told USA TODAY in May. Verma previously stated that NB.1.8.1 may be transferred more easily than LP.8.1. Additionally, he noted that NB.1.8.1 can evade antibodies created by vaccines or past infections more easily than LP.8.1. In early April, NB.1.8.1 accounted for 0% of COVID cases in the U.S. In the two weeks ending June 21, it accounted for the majority of cases at 43%, according to the CDC. The variant has similar symptoms to other strains, including fever or chills, cough, shortness of breath or difficulty breathing, sore throat, congestion or a runny nose, new loss of taste or smell, fatigue, muscle or body aches, headache, nausea or vomiting. One of its more unique features is "razor blade throat," reported by patients as an exceptionally sore throat. RFK and HHS change COVID vaccine guidance Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. said on May 27 that the COVID-19 vaccine would no longer be included in the CDC's recommended immunization schedule for healthy children and pregnant women, a move that broke with previous expert guidance and bypassed the normal scientific review process. Under the changes, the only people who will be recommended for COVID-19 vaccines are those over 65 and people with existing health problems. This could make it harder for others who want the COVID-19 vaccine to get it, including health care workers and healthy people under 65 with a vulnerable family member or those who want to reduce their short-term risk of infection. The American College of Obstetricians and Gynecologists (ACOG) and American Academy of Pediatrics (AAP), among other organizations, issued statements condemning the change, with the ACOG saying it was "...concerned about and extremely disappointed by the announcement that HHS will no longer recommend COVID-19 vaccination during pregnancy." "It is very clear that COVID-19 infection during pregnancy can be catastrophic and lead to major disability, and it can cause devastating consequences for families. The COVID-19 vaccine is safe during pregnancy, and vaccination can protect our patients and their infants after birth," President Steven J. Fleischman said in a statement. Insurance coverage typically follows federal recommendations, so anyone who is healthy and under 65 is likely to have to pay out of pocket to get the shot, which runs about $200, if they can get it. It's not clear what insurance companies will do about the new recommendations. AMA, AAP other organizations break from RFK and HHS on vaccines The American Medical Association (AMA) and American Academy of Pediatrics (AAP), in partnership with other professional medical organizations, broke from RFK and HHS after this announcement, sharing plans to develop their own guidelines independent of the government organization. In an open letter signed by 80 medical organizations across the country and published on June 25, the AMA called for physicians, healthcare networks and insurance companies to continue supporting "evidence-based immunizations to help prevent severe disease and protect public health." "Vaccines for influenza, RSV, and COVID-19 remain among the best tools to protect the public against these illnesses and their potentially serious complications—and physicians are among the most trusted voices to recommend them. We come together as physicians from every corner of medicine to reaffirm our commitment to these lifesaving vaccines," the letter said. "Recent changes to federal immunization review processes raised concerns across the medical and public health community. In this moment of uncertainty, physicians must align around clear, evidence-based guidance for patients." The AAP likewise said in a June 26 statement that it will "continue to publish its own evidence-based recommendations and schedules." AAP President Susan J. Kressly said the creation of federal immunization policy is 'no longer a credible process," adding, "...we're not stepping back, we're stepping up. The AAP will continue to publish our own immunization schedule just as we always have, developed by experts, guided by science, trusted by pediatricians and families across the country.' These latest independent guidelines have yet to be released. Vaccine committee adjourns without fresh recommendations Meanwhile, the new Advisory Committee on Immunization Practices (ACIP) gathered for the first time on June 25 in a meeting that drew criticism from some experts. RFK fired all 17 original members of the committee on June 9, replacing them with members that critics have called unqualified. Some of the members, like Kennedy, have a history of anti-vaccine advocacy, prompting backlash that had doctors and organizations calling for a delay in the meeting. Anti-vaccine sentiments were repeated by ACIP Chair Martin Kulldorf at the meeting, who said the panel will be "investigating" MMR and childhood vaccines. The CDC panel also reviewed data about COVID-19 vaccines, questioning their safety and effectiveness. They also raised questions about the study design, methodologies and surveillance monitoring systems behind the data, which Dr. Pamela Rockwell, clinical professor of family medicine at the University of Michigan Medical School, addressed as a standard of medical research. "Our efforts, through a very robust system of checks and balances, are to create vaccines and vaccination programs that result in the most benefit with the least harm," said Dr. Gretchen LaSalle, a family physician in Spokane, Washington, who represented the American Academy of Family Physicians. Despite this, the committee didn't vote on COVID-19 vaccine recommendations for the fall and isn't expected to reconvene until 'September/October,' according to the CDC website. ACIP commitee: Inside the unusual, RFK-appointed panel that's deciding on childhood vaccines FDA updates warning label for COVID vaccines The FDA likewise announced updated requirements for mRNA COVID-19 vaccine warning labels on June 25, which apply to Comirnaty by Pfizer Inc. and Spikevax by ModernaTX Inc. Prescribing information will now include warnings of the connection between the vaccines and a rare side effect that causes inflammation of the heart muscle and lining. The new warning label discloses the risk of myocarditis, which appeared in 8 cases per 1 million people who got the 2023-2024 COVID shots between the ages of 6 months and 64 years old, mostly commonly among males aged 12 to 24. The previous label, which also disclosed the risk, said the problem mostly occurred in minors aged 12-17. So, how do you protect yourself from NB.1.8.1 and other variants? Despite the back-and-forth in the U.S., the World Health Organization (WHO) has kept its recommendation consistent. Currently approved COVID-19 vaccines are expected to remain effective against the NB.1.8.1 variant, it said. In a webpage dated Jan. 7, the CDC advised that everyone over the age of six months get the 2024-2025 COVID-19 vaccine, specifically the 2024-2025 Moderna COVID-19 Vaccine. The page has since been updated with a banner, reading "COVID-19 vaccine recommendations have recently been updated for some populations. This page will be updated to align with the updated immunization schedule." The original recommendations align with the WHO's current guidelines. WHO, AMA, AAP and existing standards recommend that people who have never received a COVID-19 vaccine, are age 65 and older, are immunocompromised, live at a long-term care facility, are pregnant, breastfeeding, trying to get pregnant, and/or want to avoid getting long COVID, should get the vaccine, especially. Contributing: Greta Cross, Adrianna Rodriguez, USA TODAY
